(Q40964818)

25 September 2017

1 reference

title

Lipoprotein (a). (English)

1 reference

25 September 2017

1 reference

Durrington PN

1

1 reference

25 September 2017

publication date

1 October 1995

1 reference

Bailliere's clinical endocrinology and metabolism

25 September 2017

published in

1 reference

25 September 2017

volume

9

1 reference

25 September 2017

issue

4

1 reference

25 September 2017

page(s)

773-795

1 reference

Studies on apolipoprotein(a) phenotypes. Part 2. Phenotype frequencies and Lp(a) concentrations in different phenotypes in patients with angiographically defined coronary artery diseases

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozolol

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Serum lipoprotein (a) concentrations in patients undergoing continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Effect of HELP-LDL-apheresis on serum concentrations of human lipoprotein(a): kinetic analysis of the post-treatment return to baseline levels

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Lipoprotein(a) and accelerated coronary artery disease in cardiac transplant recipients

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

A NEW SERUM TYPE SYSTEM IN MAN—THE Lp SYSTEM

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Interaction of lipoprotein Lp(a) and low density lipoprotein with glycosaminoglycans from human aorta

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Genetics of the quantitative Lp(a) lipoprotein trait. III. Contribution of Lp(a) glycoprotein phenotypes to normal lipid variation

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Plasma lipoproteins: teaching old dogmas new tricks

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Acceleration of tensile strength of incisions treated with EGF and TGF-beta

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

The relation of lipoprotein[a] concentrations and apolipoprotein[a] phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) Study

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

The human apolipoprotein(a)/plasminogen gene cluster contains a novel homologue transcribed in liver

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Degradation of human apolipoprotein B-100 by apolipoprotein(a)

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS).

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Lipoprotein Lp(a) levels are reduced by danazol, an anabolic steroid

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Quantitation and localization of apolipoproteins [a] and B in coronary artery bypass vein grafts resected at re-operation

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Apolipoprotein E polymorphism affects plasma levels of lipoprotein(a)

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Specific anionic residues of the recombinant kringle 2 domain of tissue-type plasminogen activator that are responsible for stabilization of its interaction with omega-amino acid ligands

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Apolipoproteins (a), AI, and B and parental history in men with early onset ischaemic heart disease

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Lipoprotein (a) concentrations in postmenopausal women taking norethisterone

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Lipoprotein(a) in cirrhosis

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Prevalence of lipoprotein (a) [Lp(a)] excess in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Relationships between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and D-dimer

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Further characterization of the cellular plasminogen binding site: evidence that plasminogen 2 and lipoprotein a compete for the same site

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Proliferation of human smooth muscle cells promoted by lipoprotein(a)

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Proposed mechanisms for binding of apo[a] kringle type 9 to apo B-100 in human lipoprotein[a].

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Relationship of plasma lipoprotein Lp(a) levels to race and to apolipoprotein B.

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Decrease of Lipoprotein(a) With Improved Glycemic Control in IDDM Subjects

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Lack of association between lipoprotein (a) concentrations and coronary heart disease mortality in diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Usefulness of serum lipoprotein (a) as a predictor of restenosis after percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Lipoprotein Lp(a). A risk factor for myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Overexpression of human low density lipoprotein receptors leads to accelerated catabolism of Lp(a) lipoprotein in transgenic mice

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Free apolipoprotein (a) in abetalipoproteinaemia

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Amino acids of the recombinant kringle 1 domain of human plasminogen that stabilize its interaction with omega-amino acids

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Evolutionary origin of numerous kringles in human and simian apolipoprotein(a)

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein(a)

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Serum Lp(a) lipoprotein concentrations in insulin dependent diabetic patients with microalbuminuria

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Lipoprotein (a) and plasminogen are immunochemically related

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

A rapid increase in lipoprotein (a) levels after ethanol withdrawal in alcoholic men

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Lp(a) catabolism in hypercholesterolaemic individuals

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Catabolism of lipoprotein(a) in familial hypercholesterolaemic subjects

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Lipoprotein (a) inhibits the generation of transforming growth factor beta: an endogenous inhibitor of smooth muscle cell migration

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Lipoprotein Lp(a) and the risk for myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Changes of genetic apolipoprotein phenotypes caused by liver transplantation. Implications for apolipoprotein synthesis

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Turnover of lipoprotein (a) in man.

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Lipoprotein (a) displays increased accumulation compared with low-density lipoprotein in the murine arterial wall

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Apolipoprotein(a) phenotypes predict the risk for carotid atherosclerosis in patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Apolipoprotein(a) phenotype-associated decrease in lipoprotein(a) plasma concentrations after renal transplantation

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Assessing possible hazards of reducing serum cholesterol

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Atherogenesis in transgenic mice expressing human apolipoprotein(a)

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Macrophage proteases can modify low density lipoproteins to increase their uptake by macrophages

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

The relationship between serum levels of lipoprotein(a) and proteins associated with the acute phase response

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Lipoprotein(a) levels in black and white children and adolescents with IDDM

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Transient changes of serum lipoprotein(a) as an acute phase protein

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Lipoprotein[a] concentrations and apolipoprotein[a] phenotypes in Caucasians and African Americans. The CARDIA study.

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Identification of 34 apolipoprotein(a) isoforms: differential expression of apolipoprotein(a) alleles between American blacks and whites

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Serum concentrations of Lp(a) and other lipoprotein parameters in heavy alcohol consumers

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Apolipoprotein (a) concentrations are not related to the risk of venous thrombosis

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Lipoprotein (a): structure, properties and possible involvement in thrombogenesis and atherogenesis

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Serum lipoprotein(a) in patients heterozygous for familial hypercholesterolemia, their relatives, and unrelated control populations

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

The immediate effect of streptokinase on serum lipoprotein(a) concentration and the effect of myocardial infarction on serum lipoprotein(a), apolipoproteins A1 and B, lipids and C-reactive protein

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Serum Lp(a) lipoprotein concentration and outcome of thrombolytic treatment for myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

A potential basis for the thrombotic risks associated with lipoprotein(a).

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Molecular cloning and expression of human hepatocyte growth factor

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Alteration of lipoprotein(a) concentration with glycemic control in non-insulin-dependent diabetic subjects without diabetic complications

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Oxidative modification of lipoprotein(a) and the effect of beta-carotene

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Probucol protects lipoprotein (a) against oxidative modification

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Serum lipoprotein (a) as a risk factor for thoracic aortic atherosclerosis in subjects aged > 40 years

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Lp(a) lipoprotein in patients with arterial insufficiency of the lower extremities

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Serum lipoprotein (a) levels in maintenance hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Significance of various parameters derived from biological variability for lipid and lipoprotein analyses

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Lipoprotein (a) blood levels in unstable angina pectoris, acute myocardial infarction, and after thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Lipoprotein (a) levels in diabetes mellitus: relationship to metabolic control

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

A prospective study of lipoprotein(a) and the risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Lipoprotein(a) in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Apo(a) isoforms predict risk for coronary heart disease. A study in six populations

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Oxidation of lipoprotein Lp(a). A comparison with low-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Lipoprotein (a). Heterogeneity and biological relevance

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Lipoprotein (a) is not a risk factor for restenosis after percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Postmenopausal hormone replacement therapy, coronary heart disease and plasma lipoproteins.

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Reduction of Lp(a) by different methods of plasma exchange

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

High serum lipoprotein(a) levels are an independent risk factor for cerebral infarction

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Factors influencing the accumulation in fibrous plaques of lipid derived from low density lipoprotein. II. Preferential immobilization of lipoprotein (a) (Lp(a))

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Does lipoprotein(a) (Lp(a)) compete with plasminogen in human atherosclerotic lesions and thrombi?

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Racial (black-white) differences in serum lipoprotein (a) distribution and its relation to parental myocardial infarction in children. Bogalusa Heart Study

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Interrelationships between plasma levels of plasminogen activator inhibitor, tissue plasminogen activator, lipoprotein (a), and established cardiovascular risk factors in a north Swedish population

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Relation of lipoprotein(a) to coronary heart disease and duplexsonographic findings of the carotid arteries in heterozygous familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

The effect of moderate alcohol intake on serum apolipoprotein A-I-containing lipoproteins and lipoprotein (a)

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Effects of lipoprotein (a) on success rate of thrombolytic therapy in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Apolipoproteins and ischaemic heart disease: implications for screening

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

A study of methods of identification and estimation of Lp(a) lipoprotein and of its significance in health, hyperlipidaemia and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Does cyclosporin increase lipoprotein(a) concentrations in renal transplant recipients?

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Occlusive arterial thrombosis in cynomolgus monkeys with varying plasma concentrations of lipoprotein(a)

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Lipoprotein (a) and Microvascular Disease in Type 1 (Insulin-dependent) Diabetes

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

A cross-sectional evaluation of cardiovascular risk factors in coronary heart disease associated with Type 1 (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Improved blood glucose control by insulin therapy in type 2 diabetic patients has no effect on lipoprotein(a) levels

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Hypertension, lipoprotein(a), and apolipoprotein A-I as risk factors for stroke in the Chinese

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Lipoprotein(a) as a strong indicator for cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

Interaction of recombinant apolipoprotein(a) and lipoprotein(a) with macrophages

1 reference

https://api.crossref.org/works/10.1016/S0950-351X(95)80145-6

7 January 2021

10.1016/S0950-351X(95)80145-6

Identifiers

DOI

1 reference

25 September 2017

1 reference